Feedback / Questions
Orserdu (elacestrant) - Menarini
https://www.globenewswire.com/news-release/2025/12/08/3201538/21662/en/Menarini-Group-Presents-Elacestrant-ORSERDU-Phase-2-Combination-Data-in-Patients-with-ER-HER2-Metastatic-Breast-Cancer-mBC-at-the-2025-San-Antonio-Breast-Cancer-Symposium.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next